Linde Healthcare launches new funding for innovative gas-based
12 Nov 2010
German company Linde Healthcare has launched the Linde
Healthcare REALfund to support and stimulate novel and innovative ideas,
research and projects relating to the use of gases healthcare.
These could be, for example, solutions that can drive improvements
in clinical value, safety, patient comfort, mobility, ergonomics or
cost/benefit ratio; or solutions to support new applications for the
treatment, prevention or diagnosis of diseases or other physical
Dr Walter Koppensteiner, Head of Linde
Healthcare, said, “Expectations are that gas-based therapies and
innovative delivery devices will play crucial roles in healthcare.
The REALfund stands for Research, Evolve, Advance, Lead, and our
promise to make a real difference for patients, caregivers and
Applications are open to healthcare
practitioners, patient organisations, inventors and academic
The REALfund will support projects for new applications of gases,
devices for safe and effective application of gases or monitoring of
effects and success of gas related therapies, as well as
complementary products and services in the field.
The amount of money which will be granted will depend on the
complexity of the project but will be limited to a maximum support
of €75,000 per project. Focus areas are
acute pain management, respiratory medicine, and gas-enabled wound
care (but without excluding promising ideas from other fields).
The selection process for the REALfund will include internal experts
and representatives from the Linde Healthcare businesses. The
company will also involve external experts in the evaluation of the